Search | Caixin

: ENGLISH| 财新中文

Di Ning

Go

Chinese Vaccine-Maker Fined $1.3 Billion After Scandal

Changchun Changsheng also loses production license in punishment for falsified data, ineffective vaccines for babies
Officials Fall as Vaccine Scandal Widens

Firings highlight need for reform in industry rife with mismanagement and weak oversight
18 Arrested in Vaccine Scandal

Changchun Changsheng’s president among those detained after firm allegedly sold substandard products
Rabies Vaccine Producer Ordered to Halt Production

Health agency orders suspension after discovering altered production data
China Paves Way for Faster Approval of Foreign-Made Drugs

Pharmaceutical firms to be able to submit certain new medicines simultaneously inside, outside China
Merck’s HPV Vaccine Wins Lightning-Fast Approval

Green light shows drug regulator has recognized China’s urgent need for Gardasil 9
Merck’s Improved HPV Vaccine Awaits Approval in China

Gardasil 9 protects against more strains of sexually transmitted virus that can cause cancer
Good Doctor Aims to Raise $1.1 Billion in Hong Kong IPO

Ping An’s health care unit to offer retail investors 6.5% of shares, with rest targeted at international institutional investors
China to Eliminate Cancer Drug Import Tariffs

Analysts warn move may not be enough to make medication more affordable

About Caixin | Contact Us | Customer Support | Work with Caixin | Press | Register | Newsletter | App | FAQ

The Wall Street Journal | South China Morning Post | CNBC | MarketWatch | The Guardian | Global Times

Privacy Policy | Terms and Conditions

Copyright © 2017 Caixin Global Limited. All Rights Reserved.